• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Regulation of ENT1 expression and ENT1-dependent nucleoside transport by c-Jun N-terminal kinase.c-Jun N-端激酶对 ENT1 表达和 ENT1 依赖的核苷转运的调节。
Biochem Biophys Res Commun. 2011 Jan 7;404(1):370-5. doi: 10.1016/j.bbrc.2010.11.125. Epub 2010 Dec 9.
2
Molecular cloning and functional characterization of inhibitor-sensitive (mENT1) and inhibitor-resistant (mENT2) equilibrative nucleoside transporters from mouse brain.来自小鼠脑的抑制剂敏感型(mENT1)和抑制剂抗性型(mENT2)平衡核苷转运体的分子克隆与功能特性分析
Biochem J. 2000 Dec 1;352 Pt 2(Pt 2):363-72.
3
Development of a Novel HEK293 Cell Model Lacking to Study the Pharmacology of Endogenous -Encoded Equilibrative Nucleoside Transporter Subtype 2.开发一种新型 HEK293 细胞模型以研究内源性编码的核苷转运蛋白亚型 2 的药理学。
Drug Metab Dispos. 2024 Sep 16;52(10):1094-1103. doi: 10.1124/dmd.124.001814.
4
Characterization of mENT1Delta11, a novel alternative splice variant of the mouse equilibrative nucleoside transporter 1.小鼠平衡核苷转运体1的一种新型可变剪接变体mENT1Delta11的特性分析
Mol Pharmacol. 2008 Jul;74(1):264-73. doi: 10.1124/mol.107.041871. Epub 2008 Apr 15.
5
ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.ZIP4 通过增加转录因子 ZEB1 的表达来促进整合素 α3β1 信号转导并抑制胰腺癌细胞中吉西他滨转运蛋白 ENT1 的表达。
Gastroenterology. 2020 Feb;158(3):679-692.e1. doi: 10.1053/j.gastro.2019.10.038. Epub 2019 Nov 9.
6
Cloning of a novel isoform of the mouse NBMPR-sensitive equilibrative nucleoside transporter (ENT1) lacking a putative phosphorylation site.缺乏假定磷酸化位点的小鼠NBMPR敏感性平衡核苷转运体(ENT1)新亚型的克隆
Gene. 2001 Jan 10;262(1-2):301-7. doi: 10.1016/s0378-1119(00)00555-2.
7
Gene-expression profiling reveals down-regulation of equilibrative nucleoside transporter 1 (ENT1) in Ara-C-resistant CCRF-CEM-derived cells.基因表达谱分析显示,在阿糖胞苷耐药的CCRF-CEM来源细胞中,平衡核苷转运体1(ENT1)表达下调。
J Biochem. 2004 Nov;136(5):733-40. doi: 10.1093/jb/mvh180.
8
Absence of equilibrative nucleoside transporter 1 in ENT1 knockout mice leads to altered nucleoside levels following hypoxic challenge.ENT1 敲除小鼠中不存在平衡核苷转运蛋白 1,导致缺氧应激后核苷水平改变。
Life Sci. 2011 Oct 24;89(17-18):621-30. doi: 10.1016/j.lfs.2011.08.007. Epub 2011 Aug 17.
9
Characterization and functional analysis of the promoter for the human equilibrative nucleoside transporter gene, hENT1.
Nucleosides Nucleotides Nucleic Acids. 2007;26(1):99-110. doi: 10.1080/15257770601052331.
10
Equilibrative Nucleoside Transporter 1 (ENT1, ) Facilitates Transfer of the Antiretroviral Drug Abacavir across the Placenta.平衡核苷转运蛋白 1(ENT1,)有助于抗逆转录病毒药物阿巴卡韦穿过胎盘。
Drug Metab Dispos. 2018 Nov;46(11):1817-1826. doi: 10.1124/dmd.118.083329. Epub 2018 Aug 10.

引用本文的文献

1
Sodium Caseinate Induces Apoptosis in Cytarabine-Resistant AML by Modulating SIRT1 and Chemoresistance Genes, Alone or in Combination with Cytarabine or Daunorubicin.酪蛋白酸钠通过调节SIRT1和化疗耐药基因,单独或与阿糖胞苷或柔红霉素联合使用,诱导阿糖胞苷耐药的急性髓系白血病细胞凋亡。
Int J Mol Sci. 2025 Aug 1;26(15):7468. doi: 10.3390/ijms26157468.
2
Mutant p53 Associates with Human Equilibrative Nucleoside 1 Upregulation and Better Response to Adjuvant Gemcitabine in Intrahepatic Cholangiocarcinoma Patients.突变型p53与肝内胆管癌患者人平衡核苷转运体1上调及对吉西他滨辅助治疗的更好反应相关。
Int J Mol Sci. 2025 May 30;26(11):5259. doi: 10.3390/ijms26115259.
3
The JNK Signaling Pathway Regulates Seizures Through ENT1 in Pilocarpine-Induced Epilepsy Rat Model.在匹罗卡品诱导的癫痫大鼠模型中,JNK信号通路通过ENT1调节癫痫发作。
CNS Neurosci Ther. 2024 Dec;30(12):e70190. doi: 10.1111/cns.70190.
4
Extracellular adenosine oppositely regulates the purinome machinery in glioblastoma and mesenchymal stem cells.细胞外腺苷在胶质母细胞瘤和间充质干细胞中反向调节嘌呤核苷体系。
IUBMB Life. 2024 Dec;76(12):1234-1251. doi: 10.1002/iub.2905. Epub 2024 Aug 12.
5
Oncopig bladder cancer cells recapitulate human bladder cancer treatment responses .基因编辑猪膀胱癌细胞重现人类膀胱癌的治疗反应。
Front Oncol. 2024 Feb 26;14:1323422. doi: 10.3389/fonc.2024.1323422. eCollection 2024.
6
Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities.核苷转运体与肿瘤微环境中的免疫抑制性腺苷信号:潜在的治疗机会。
Pharmacol Ther. 2022 Dec;240:108300. doi: 10.1016/j.pharmthera.2022.108300. Epub 2022 Oct 22.
7
Integrin β1 in Pancreatic Cancer: Expressions, Functions, and Clinical Implications.胰腺癌中的整合素β1:表达、功能及临床意义
Cancers (Basel). 2022 Jul 11;14(14):3377. doi: 10.3390/cancers14143377.
8
Toward a Molecular Basis of Cellular Nucleoside Transport in Humans.朝向人类细胞核苷转运的分子基础。
Chem Rev. 2021 May 12;121(9):5336-5358. doi: 10.1021/acs.chemrev.0c00644. Epub 2020 Nov 24.
9
The failure of DAC to induce OCT2 expression and its remission by hemoglobin-based nanocarriers under hypoxia in renal cell carcinoma.缺氧条件下 DAC 未能诱导肾细胞癌中 OCT2 的表达及其被血红蛋白纳米载体逆转。
Theranostics. 2020 Feb 18;10(8):3562-3578. doi: 10.7150/thno.39944. eCollection 2020.
10
ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.ZIP4 通过增加转录因子 ZEB1 的表达来促进整合素 α3β1 信号转导并抑制胰腺癌细胞中吉西他滨转运蛋白 ENT1 的表达。
Gastroenterology. 2020 Feb;158(3):679-692.e1. doi: 10.1053/j.gastro.2019.10.038. Epub 2019 Nov 9.

本文引用的文献

1
Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.人平衡核苷转运体1水平可预测胰腺癌患者对吉西他滨的反应。
Gastroenterology. 2009 Jan;136(1):187-95. doi: 10.1053/j.gastro.2008.09.067. Epub 2008 Oct 7.
2
Imatinib-resistant CML cells have low ENT activity but maintain sensitivity to gemcitabine.伊马替尼耐药的慢性粒细胞白血病细胞ENT活性较低,但对吉西他滨仍保持敏感。
Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):779-86. doi: 10.1080/15257770802145892.
3
Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells.人类白血病细胞中阿糖胞苷耐药性的两种不同分子机制。
Cancer Res. 2008 Apr 1;68(7):2349-57. doi: 10.1158/0008-5472.CAN-07-5528.
4
Compensatory effects of the human nucleoside transporters on the response to nucleoside-derived drugs in breast cancer MCF7 cells.人核苷转运体对乳腺癌MCF7细胞中核苷衍生药物反应的补偿作用。
Biochem Pharmacol. 2008 Feb 1;75(3):639-48. doi: 10.1016/j.bcp.2007.10.005. Epub 2007 Oct 13.
5
Nucleoside and nucleobase transporters of primary human cardiac microvascular endothelial cells: characterization of a novel nucleobase transporter.原代人心脏微血管内皮细胞的核苷和核碱基转运体:一种新型核碱基转运体的特性
Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3325-32. doi: 10.1152/ajpheart.01006.2007. Epub 2007 Oct 5.
6
Differential regulation of mouse equilibrative nucleoside transporter 1 (mENT1) splice variants by protein kinase CK2.蛋白激酶CK2对小鼠平衡核苷转运体1(mENT1)剪接变体的差异调节
Mol Membr Biol. 2007 Jul-Aug;24(4):294-303. doi: 10.1080/09687860701210617.
7
Regulation of drug transporters during infection and inflammation.感染和炎症期间药物转运体的调控
Mol Interv. 2007 Apr;7(2):99-111. doi: 10.1124/mi.7.2.10.
8
The c-jun kinase/stress-activated pathway: regulation, function and role in human disease.c-jun激酶/应激激活途径:在人类疾病中的调控、功能及作用
Biochim Biophys Acta. 2007 Aug;1773(8):1341-8. doi: 10.1016/j.bbamcr.2006.12.009. Epub 2007 Jan 4.
9
Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer.胰腺癌中抗癌药物敏感性的药物遗传学
Mol Cancer Ther. 2006 Jun;5(6):1387-95. doi: 10.1158/1535-7163.MCT-06-0004.
10
Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes.一氧化氮可降低妊娠期糖尿病患者胎儿内皮细胞中腺苷转运体ENT1基因(SLC29A1)的启动子活性。
J Cell Physiol. 2006 Aug;208(2):451-60. doi: 10.1002/jcp.20680.

c-Jun N-端激酶对 ENT1 表达和 ENT1 依赖的核苷转运的调节。

Regulation of ENT1 expression and ENT1-dependent nucleoside transport by c-Jun N-terminal kinase.

机构信息

Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, NC 27599-7365, USA.

出版信息

Biochem Biophys Res Commun. 2011 Jan 7;404(1):370-5. doi: 10.1016/j.bbrc.2010.11.125. Epub 2010 Dec 9.

DOI:10.1016/j.bbrc.2010.11.125
PMID:21145879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3018549/
Abstract

Equilibrative nucleoside transporters (ENTs) are facilitative transporters broadly selective for pyrimidine and purine nucleosides and are essential for the modulation of nucleoside concentration and nucleoside analog availability. Resistance to nucleoside-derived drugs strongly correlates with a deficiency of ENT1 expression in several tumor cells. Thus, it is crucial to understand the mechanisms by which this transporter is modulated. Using a mouse myeloid leukemic cell line as a model, we investigated whether stress-activated kinases regulate ENT1 expression and function. JNK activation, but not p38 MAPK results in rapid loss of mENT1 function, mRNA expression and promoter activity. c-Jun but not the mutant c-Jun Ser63/73Ala, decreased mENT1 promoter activity. Moreover cJun bound to an AP-1 site identified at -1196 of the promoter, suggesting a specific role for this transcription factor in mENT1 regulation. We propose that activation of JNK-cJun pathway negatively regulates mENT1 and suggest that this mechanism might contribute to the development of nucleoside analog-derived drug resistance.

摘要

平衡核苷转运体(ENTs)是一种广泛选择性嘧啶和嘌呤核苷的易化转运体,对于调节核苷浓度和核苷类似物的可用性至关重要。几种肿瘤细胞中 ENT1 表达的缺乏与对核苷衍生药物的耐药性强烈相关。因此,了解这种转运体被调节的机制至关重要。我们使用小鼠髓样白血病细胞系作为模型,研究了应激激活的激酶是否调节 ENT1 的表达和功能。JNK 的激活,而不是 p38 MAPK,导致 mENT1 功能、mRNA 表达和启动子活性的快速丧失。c-Jun 但不是突变的 c-Jun Ser63/73Ala,降低了 mENT1 启动子活性。此外,cJun 与启动子-1196 处鉴定的 AP-1 位点结合,表明该转录因子在 mENT1 调节中具有特定作用。我们提出 JNK-cJun 途径的激活负调节 mENT1,并表明这种机制可能有助于核苷类似物衍生药物耐药性的发展。